Pubblicazioni

Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection

2024 - EXPERT REVIEW OF VACCINES

Domnich, Alexander; Orsi, Andrea; Signori, Alessio; Chironna, Maria; Manini, Ilaria; Napoli, Christian; Rizzo, Caterina; Panatto, Donatella; Icardi, Giancarlo

Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged â¥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021

2022 - EXPERT REVIEW OF VACCINES

Fabiani, Massimo; Puopolo, Maria; Filia, Antonietta; Sacco, Chiara; Mateo-Urdiales, Alberto; Spila Alegiani, Stefania; Del Manso, Martina; D'Ancona, Fortunato; Vescio, Fenicia; Bressi, Marco; Petrone, Daniele; Spuri, Matteo; Rota, Maria Cristina; Massari, Marco; Da Cas, Roberto; Morciano, Cristina; Stefanelli, Paola; Bella, Antonino; Tallon, Marco; Proietti, Valeria; Siddu, Andrea; Battilomo, Serena; Palamara, Anna Teresa; Popoli, Patrizia; Brusaferro, Silvio; Rezza, Giovanni; Riccardo, Flavia; Menniti Ippolito, Francesca; Pezzotti, Patrizio

Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017â2018 season

2019 - EXPERT REVIEW OF VACCINES

Bella, A.; Gesualdo, F.; Orsi, A.; Arcuri, C.; Chironna, M.; Loconsole, D.; Napoli, C.; Orsi, G. B.; Manini, I.; Montomoli, E.; Alfonsi, V.; Castrucci, M. R.; Rizzo, C.

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

2016 - EXPERT REVIEW OF VACCINES

Vici, P; Pizzuti, L; Mariani, L; Zampa, G; Santini, D; Di Lauro, L; Gamucci, T; Natoli, C; Barba, M; Maugeri SaccÃ , M; Sergi, D; Tomao, Federica; Vizza, E; Di Filippo, S; Paolini, F; Curzio, G; Corrado, G; Michelotti, A; Sanguineti, G; Giordano, A; De Maria, R; Venuti, A.; Marchetti, Paolo

Pubblicazioni

Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection

Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged â¥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021

Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017â2018 season

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged â¥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021

Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017â2018 season